Xencor | XNCR - Market Capitalization



Xencor reported $511.6M in Market Capitalization this September of 2025, considering the latest stock price and the number of outstanding shares.


Market Capitalization Change Date
AbbVie USD 327.88B 42.76B Jun/2025
Alnylam Pharmaceuticals USD 42.52B 7.39B Jun/2025
Amgen USD 150.13B 17.37B Jun/2025
Arrowhead Research USD 2.18B 433M Jun/2025
AstraZeneca GBP 215.51B 41B Jun/2025
Biogen USD 18.41B 1.62B Jun/2025
Bristol-Myers Squibb USD 94.2B 29.9B Jun/2025
Cytokinetics USD 3.95B 846M Jun/2025
GlaxoSmithKline GBP 56.24B 4.11B Jun/2025
J&J USD 366.71B 32.94B Jun/2025
MacroGenics USD 111M 34M Sep/2025
Merck USD 198.77B 27.1B Jun/2025
Novartis CHF 256.18B 64.49B Jun/2025
Pfizer USD 137.53B 6.19B Jun/2025
Regeneron Pharmaceuticals USD 55.87B 13.47B Jun/2025
Xencor USD 559M 191M Jun/2025